10-K Decoder · All companies

Alto Neuroscience, Inc.

ANRO · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$66.4M−$68.6M+3.3%
Net income−$63.2M−$61.4M−2.9%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$27.2M−$15.0M−81.3%
Net income−$25.1M−$14.2M−76.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Alto Neuroscience's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Alto Neuroscience profitable in FY2025?
No: net income was −$63.2M and operating income −$66.4M in FY2025.
What was Alto Neuroscience's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 10, 2026.